Modulight Corporation?has received a purchase order from an existing neurology customer on April 20, 2022. This customer's application is in the field of diagnostics, while Modulight has already other customers using the same technology for treatment of brain cancer. The customer is a private US company.

The total value of the order is $3.9 million (approx. EUR 3.6 million). Monthly deliveries are planned for the period third quarter of 2022 – second quarter of 2023 and the order is recognized as revenue based on the deliveries during this period.